274 related articles for article (PubMed ID: 36929701)
1. Insights into the cellular consequences of LRRK2-mediated Rab protein phosphorylation.
Fasiczka R; Naaldijk Y; Brahmia B; Hilfiker S
Biochem Soc Trans; 2023 Apr; 51(2):587-595. PubMed ID: 36929701
[TBL] [Abstract][Full Text] [Related]
2. LRRK2 phosphorylation of Rab GTPases in Parkinson's disease.
Pfeffer SR
FEBS Lett; 2023 Mar; 597(6):811-818. PubMed ID: 36114007
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 and Rab GTPases.
Pfeffer SR
Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
[TBL] [Abstract][Full Text] [Related]
5. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
[TBL] [Abstract][Full Text] [Related]
6. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
[TBL] [Abstract][Full Text] [Related]
7. Development of phospho-specific Rab protein antibodies to monitor
Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR
Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256
[TBL] [Abstract][Full Text] [Related]
8. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.
Cookson MR
Biochem Soc Trans; 2016 Dec; 44(6):1603-1610. PubMed ID: 27913668
[TBL] [Abstract][Full Text] [Related]
9. Localization of PPM1H phosphatase tunes Parkinson's disease-linked LRRK2 kinase-mediated Rab GTPase phosphorylation and ciliogenesis.
Yeshaw WM; Adhikari A; Chiang CY; Dhekne HS; Wawro PS; Pfeffer SR
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2315171120. PubMed ID: 37889931
[TBL] [Abstract][Full Text] [Related]
10. Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.
Nirujogi RS; Tonelli F; Taylor M; Lis P; Zimprich A; Sammler E; Alessi DR
Biochem J; 2021 Jan; 478(2):299-326. PubMed ID: 33367571
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms.
Malik AU; Karapetsas A; Nirujogi RS; Mathea S; Chatterjee D; Pal P; Lis P; Taylor M; Purlyte E; Gourlay R; Dorward M; Weidlich S; Toth R; Polinski NK; Knapp S; Tonelli F; Alessi DR
Biochem J; 2021 Feb; 478(3):553-578. PubMed ID: 33459343
[TBL] [Abstract][Full Text] [Related]
12. The Role of LRRK2 in Intracellular Organelle Dynamics.
Boecker CA
J Mol Biol; 2023 Jun; 435(12):167998. PubMed ID: 36764357
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson's disease-linked LRRK2 kinase.
Dhekne HS; Tonelli F; Yeshaw WM; Chiang CY; Limouse C; Jaimon E; Purlyte E; Alessi DR; Pfeffer SR
Elife; 2023 Oct; 12():. PubMed ID: 37874635
[TBL] [Abstract][Full Text] [Related]
14. Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.
Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Gómez-Suaga P; Waschbüsch D; Lobbestael E; Baekelandt V; Nairn AC; Ruiz-Martínez J; Aiastui A; López de Munain A; Lis P; Comptdaer T; Taymans JM; Chartier-Harlin MC; Beilina A; Gonnelli A; Cookson MR; Greggio E; Hilfiker S
Mol Neurodegener; 2018 Jan; 13(1):3. PubMed ID: 29357897
[TBL] [Abstract][Full Text] [Related]
15. An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease.
Komori T; Kuwahara T
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002327
[TBL] [Abstract][Full Text] [Related]
16. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner
McGrath E; Waschbüsch D; Baker BM; Khan AR
Small GTPases; 2021 Mar; 12(2):133-146. PubMed ID: 31552791
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology.
Fujimoto T; Kuwahara T; Eguchi T; Sakurai M; Komori T; Iwatsubo T
Biochem Biophys Res Commun; 2018 Jan; 495(2):1708-1715. PubMed ID: 29223392
[TBL] [Abstract][Full Text] [Related]
19. Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytes.
Unapanta A; Shavarebi F; Porath J; Shen Y; Balen C; Nguyen A; Tseng J; Leong WS; Liu M; Lis P; Di Pietro SM; Hiniker A
J Biol Chem; 2023 Oct; 299(10):105192. PubMed ID: 37625589
[TBL] [Abstract][Full Text] [Related]
20. The Cell Biology of LRRK2 in Parkinson's Disease.
Usmani A; Shavarebi F; Hiniker A
Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33526455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
